DB-OTO is a cell-selective, dual adeno-associated virus vector gene therapy that aims to restore hearing by delivering a functional OTOF gene to the inner hair cells of the cochlea. This research ...
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback